Clinical Trial » Intervention type » Drug

Drug

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-Induced Dyskinesias in Advanced Parkinson's Disease
31 May 2009
The study is designed to measure the efficacy and safety of levetiracetam on levodopa-induced dyskinesias in late-stage Parkinson's disease. The patients are planned to be treated with levetiracetam ... 
Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
31 May 2009
TD is a troublesome and potentially irreversible side effect associated with the use of neuroleptics. While the newer neuroleptics are improved in this regard, they all still carry the ... 
Sarizotan in Parkinson Patients With L-Dopa-Induced Dyskinesia
31 May 2009
The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship ... 
A Study of T2000 in Essential Tremor
31 May 2009
This study will evaluate the safety and efficacy of T2000 when used to treat patients with moderate to severe essential tremor over a 20 week period. Essential tremor (ET) is a common form of ... 
Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease
31 May 2009
This is a double blind, placebo-controlled clinical trial of 15 months duration designed to examine early Mirapex (pramipexole) treatment vs. delayed Mirapex (pramipexole) treatment in ... 
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
31 May 2009
In Parkinson's Disease, the mitochondrial membranes in cells that produce dopamine become damaged by oxidants, leading to the death of these cells and progressive tremor, slowness of ... 
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
31 May 2009
This study was designed to compare the effectiveness and tolerability of a new prolonged release formulation of ropinirole with the currently marketed immediate release formulation which ... 
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
31 May 2009
Antidepressant medicines sometimes cause sexual side effects. The purpose of this study is to determine whether the sexual dysfunction sometimes caused by selective serotonin reuptake ... 
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
31 May 2009
The primary objective of this study will be to provide further evidence of the long-term safety and tolerability of levodopa-carbidopa intestinal gel (Duodopa®) over 6-12-months in ... 
SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease
31 May 2009
This is a multicenter, randomized, double blind, parallel group study of 6 months' treatment with SLV308 as monotherapy in patients with early stage PD. An open label safety extension to ... 
Syndicate content